Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Novel health care strategies for melanoma in children, adolescents and young adults

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Partner registration status (si apre in una nuova finestra)

List of partners identified in level of involvement.

Policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting 1 (si apre in una nuova finestra)

Report on policy brief formulating recommendations based on the research and innovation strand of the ‘Understanding’ annual cluster meeting

Immuno-Ped initiation package (si apre in una nuova finestra)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Standardized protocols for tumor tissue processing (si apre in una nuova finestra)

Document detailing the standardized protocols for tumor tissue processing (inclusion, orientation of the sample, sectioning, etc)

Dissemination & communication plan 1 (si apre in una nuova finestra)

Document describing the dissemination and communication plan

Project Management Plan (si apre in una nuova finestra)

Document describing the management plan for MELCAYA project

Plan for ethic-legal monitoring & ethical submissions 1 (si apre in una nuova finestra)

Document detailing the plan for ethic-legal monitoring & ethical submissions

Common work plan for scientific collaboration under the ‘Understanding’ cluster (si apre in una nuova finestra)

Report on the common work plan for scientific collaboration under the ‘Understanding’ cluster

NevustoMel initiation package (si apre in una nuova finestra)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Patient engagement plan (si apre in una nuova finestra)

Detailed plan for patient engagement

AI-MEL initiation package (si apre in una nuova finestra)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.AI-MEL study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project.

Plan for ethic-legal monitoring & ethical submissions 2 (si apre in una nuova finestra)

Document detailing the plan for ethic-legal monitoring & ethical submissions

Conclusions of common annual meeting of the ‘Understanding’ cluster 1 (si apre in una nuova finestra)

Report on the conclusions of common annual meeting of the ‘Understanding’ cluster

Precis-mel initiation package (si apre in una nuova finestra)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.The study protocol will include information about how humans will maintain meaningful control over the decision-making process for the use of the prediction and diagnostic tool to be developed in the project. No further deliverables will be required.

Quality Assurance and Risk Management Plan (si apre in una nuova finestra)

Document detailing the Quality Assurance and Risk Management Plan

ExpoMel initiation package (si apre in una nuova finestra)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Mol-Mel initiation package (si apre in una nuova finestra)

- Registration number of the clinical study in a registry meeting WHO Registry criteria.- Final version of study protocol as approved by the regulators/ethics committee.- Regulatory and ethics approvals required for the enrolment of the first study participant.Study protocol will include information about if and how the incidental (or secondary) findings will be communicated to participants and how the personal data will be processed. Study protocol will also include information about how the retrospective and prospective personal data will be processed and also about the anonymization/pseudoanonymisation techniques that will be implemented.

Common video and/or a common cluster brochure (si apre in una nuova finestra)

Video and/or common cluster brochure of the projects included in the Mission Cancer Cluster 'Understanding'.

Project Website (si apre in una nuova finestra)

MELCAYA webpage with public and private domains

Online and media presence 1 (si apre in una nuova finestra)

Document with the summary of all on line MELCAYA post, citations and interactions

Data Management Plan 1 (si apre in una nuova finestra)

Document detailing the Data Management PlanThe preparation of the Data Management Plan will include a common chapter onthe ‘Understanding’ cluster. The aim of the chapter is to addresscommonalities in data standards, data validation, data protection andfostering data exchange, in particular when it comes to sharing project datawith a future federated UNCAN.eu data platform. Therefore, interactions areenvisaged with the 4.UNCAN.eu (http://uncaninitiative.eu/) coordination andsupport action which is preparing a blueprint for UNCAN.eu.

Pubblicazioni

Braf-mutant Schwann cells divert to a repair phenotype to induce congenital demyelinating neuropathy (si apre in una nuova finestra)

Autori: Elise Marechal, Patrice Quintana, Daniel Aldea, Grégoire Mondielli, Nathalie Bernard-Marissal, Mathias Moreno, Valérie Delague, Lauren A. Weiss, Anne Barlier, Heather C. Etchevers
Pubblicato in: bioRxiv, 2024, ISSN 1531-6386
Editore: bioRxiv
DOI: 10.1101/2024.04.24.590951

È in corso la ricerca di dati su OpenAIRE...

Si è verificato un errore durante la ricerca dei dati su OpenAIRE

Nessun risultato disponibile

Il mio fascicolo 0 0